![Checkpoint Therapeutics Inc](/common/images/company/N_CKPT.png)
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodie... Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -4.5584045584 | 3.51 | 3.56 | 3.02 | 741426 | 3.27795787 | CS |
4 | 0 | 0 | 3.35 | 3.86 | 2.68 | 869142 | 3.15361578 | CS |
12 | -0.14 | -4.01146131805 | 3.49 | 4.5 | 2.68 | 1418995 | 3.51539275 | CS |
26 | 1.12 | 50.2242152466 | 2.23 | 4.5 | 2.06 | 976865 | 3.34426559 | CS |
52 | 1.38 | 70.0507614213 | 1.97 | 4.5 | 1.38 | 692454 | 2.96129446 | CS |
156 | -18.35 | -84.5622119816 | 21.7 | 21.9 | 1.3 | 530053 | 5.74853467 | CS |
260 | -19.35 | -85.2422907489 | 22.7 | 53.762 | 1.3 | 709148 | 18.93768392 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관